- Introduction - Procedures - Regulation - Fees - FAQ's - Workshops and Training - Implementation of the National Innovation Office: consultation procedure
15/03/2024 Marketing authorisation holders: mandatory update of contact details in product information for reporting adverse reactions to the FAMHP
14/03/2024 PRAC March 2024 – PRAC finds no link between postmenopausal bleeding and mRNA COVID-19 vaccines
21/02/2024 PRAC February 2024: reminder of serious adverse reactions when Paxlovid is taken in combination with certain immunosuppressants